Parisi Samuel Joseph
Known title: VP, Finance (Interim PAO)CIK: 0002010945
Associated companies
Transaction History
| ALKS | ▲ Buy | Option Exercise | 3,392 | $68K | 5/29/2026 | View on chart |
| ALKS | ▼ Sell | Open Market | 16,217 | $687K | 5/29/2026 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 12,825 | $248K | 5/29/2026 | View on chart |
| ALKS | ▼ Sell | Open Market | 6,890 | $202K | 3/2/2026 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 2,747 | — | 2/26/2026 | View on chart |
| ALKS | ▼ Sell | Tax Withholding | 808 | $25K | 2/26/2026 | View on chart |
| ALKS | ▼ Sell | Tax Withholding | 672 | $22K | 2/23/2026 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 2,283 | — | 2/23/2026 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 2,991 | — | 2/19/2026 | View on chart |
| ALKS | ▼ Sell | Tax Withholding | 979 | $31K | 2/19/2026 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 2,034 | — | 2/18/2026 | View on chart |
| ALKS | ▼ Sell | Tax Withholding | 706 | $23K | 2/18/2026 | View on chart |
| ALKS | ▼ Sell | Open Market | 1,938 | $66K | 2/28/2025 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 2,746 | — | 2/26/2025 | View on chart |
| ALKS | ▼ Sell | Tax Withholding | 808 | $28K | 2/26/2025 | View on chart |
| ALKS | ▼ Sell | Open Market | 3,743 | $132K | 2/25/2025 | View on chart |
| ALKS | ▼ Sell | Tax Withholding | 672 | $24K | 2/23/2025 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 2,284 | — | 2/23/2025 | View on chart |
| ALKS | ▼ Sell | Tax Withholding | 983 | $35K | 2/22/2025 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 3,114 | — | 2/22/2025 | View on chart |
| ALKS | ▼ Sell | Open Market | 1,327 | $47K | 2/20/2025 | View on chart |
| ALKS | ▼ Sell | Tax Withholding | 706 | $25K | 2/18/2025 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 2,033 | — | 2/18/2025 | View on chart |
| ALKS | ▼ Sell | Open Market | 2,559 | $76K | 2/27/2024 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 2,283 | — | 2/23/2024 | View on chart |
| ALKS | ▼ Sell | Tax Withholding | 672 | $20K | 2/23/2024 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 3,114 | — | 2/22/2024 | View on chart |
| ALKS | ▼ Sell | Tax Withholding | 908 | $26K | 2/22/2024 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 1,872 | — | 2/20/2024 | View on chart |
| ALKS | ▼ Sell | Tax Withholding | 641 | $19K | 2/20/2024 | View on chart |
| ALKS | ▼ Sell | Tax Withholding | 706 | $23K | 2/18/2024 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 2,034 | — | 2/18/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
Baird Highlights Growth Potential for Alkermes plc (ALKS)
Baird has highlighted Alkermes plc as a company with promising growth potential, citing its pipeline and recent developments. A Yahoo article compares Alkermes to LQDA, discussing which biotech may be more attractive for investors. The stock is currently trading near its 200‑day moving average and close to a key support level of $48.74, while analysts average a target of $56.56.
Baird Highlights Growth Potential for Alkermes plc (ALKS). Baird has highlighted Alkermes plc as a company with promising growth potential, citing its pipeline and recent developments. A Yahoo article compares Alkermes to LQDA, discussing which biotech may be more attractive for investors. The stock is currently trading near its 200‑day moving average and close to a key support level of $48.74, while analysts average a target of $56.56.